Manufacturers Life Insurance Company, The Halozyme Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

  • $109 Billion
  • Q4 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 283,870 shares of HALO stock, worth $18.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
283,870
Previous 260,355 9.03%
Holding current value
$18.1 Million
Previous $14.9 Million 8.88%
% of portfolio
0.01%
Previous 0.01%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$42.57 - $61.09 $1 Million - $1.44 Million
23,515 Added 9.03%
283,870 $13.6 Million
Q3 2024

Nov 13, 2024
SELL
$51.3 - $64.42 $250,395 - $314,434
-4,881 Reduced 1.84%
260,355 $14.9 Million
Q2 2024

Aug 14, 2024
SELL
$37.81 - $52.4 $92,142 - $127,698
-2,437 Reduced 0.91%
265,236 $13.9 Million
Q1 2024

May 14, 2024
BUY
$33.68 - $41.95 $599,335 - $746,500
17,795 Added 7.12%
267,673 $10.9 Million
Q4 2023

Feb 13, 2024
SELL
$33.32 - $42.1 $137,378 - $173,578
-4,123 Reduced 1.62%
249,878 $9.24 Million
Q3 2023

Nov 15, 2023
BUY
$36.46 - $44.03 $1.24 Million - $1.49 Million
33,890 Added 15.4%
254,001 $9.7 Million
Q2 2023

Aug 11, 2023
SELL
$30.28 - $38.74 $30,461 - $38,972
-1,006 Reduced 0.45%
220,111 $7.94 Million
Q1 2023

May 15, 2023
SELL
$32.86 - $55.7 $75,216 - $127,497
-2,289 Reduced 1.04%
218,828 $8.36 Million
Q4 2022

Aug 11, 2023
SELL
$40.06 - $59.44 $636,673 - $944,679
-15,893 Reduced 6.71%
221,117 $12.6 Million
Q4 2022

Feb 13, 2023
SELL
$40.06 - $59.44 $636,673 - $944,679
-15,893 Reduced 6.71%
221,117 $12.6 Million
Q3 2022

Aug 11, 2023
SELL
$38.53 - $51.78 $383,103 - $514,848
-9,943 Reduced 4.03%
237,010 $9.37 Million
Q3 2022

Nov 03, 2022
SELL
$38.53 - $51.78 $383,103 - $514,848
-9,943 Reduced 4.03%
237,010 $9.37 Million
Q2 2022

Aug 11, 2023
SELL
$37.35 - $48.3 $32,046 - $41,441
-858 Reduced 0.35%
246,953 $10.9 Million
Q2 2022

Aug 15, 2022
SELL
$37.35 - $48.3 $32,046 - $41,441
-858 Reduced 0.35%
246,953 $11 Million
Q1 2022

Aug 11, 2023
BUY
$31.97 - $41.06 $926,586 - $1.19 Million
28,983 Added 13.24%
247,811 $9.88 Million
Q1 2022

May 20, 2022
BUY
$31.97 - $41.06 $683,294 - $877,575
21,373 Added 9.44%
247,811 $9.91 Million
Q4 2021

Feb 16, 2022
SELL
$31.82 - $40.75 $6.53 Million - $8.36 Million
-205,111 Reduced 47.53%
226,438 $9.11 Million
Q3 2021

Nov 12, 2021
BUY
$38.47 - $46.42 $8.01 Million - $9.67 Million
208,314 Added 93.32%
431,549 $17.6 Million
Q2 2021

Aug 12, 2021
BUY
$38.84 - $51.31 $319,187 - $421,665
8,218 Added 3.82%
223,235 $10.1 Million
Q1 2021

May 03, 2021
SELL
$39.51 - $51.45 $587,000 - $764,392
-14,857 Reduced 6.46%
215,017 $8.96 Million
Q4 2020

Feb 12, 2021
BUY
$25.81 - $43.62 $3.9 Million - $6.6 Million
151,245 Added 192.35%
229,874 $9.82 Million
Q3 2020

Nov 09, 2020
SELL
$25.74 - $29.63 $57,631 - $66,341
-2,239 Reduced 2.77%
78,629 $2.07 Million
Q2 2020

Aug 10, 2020
SELL
$16.25 - $26.81 $108,777 - $179,466
-6,694 Reduced 7.64%
80,868 $2.09 Million
Q1 2020

May 15, 2020
BUY
$13.9 - $21.83 $21,239 - $33,356
1,528 Added 1.78%
87,562 $1.58 Million
Q4 2019

Feb 14, 2020
SELL
$14.93 - $19.53 $44,327 - $57,984
-2,969 Reduced 3.34%
86,034 $1.53 Million
Q3 2019

Nov 12, 2019
SELL
$15.2 - $17.69 $4,438 - $5,165
-292 Reduced 0.33%
89,003 $1.35 Million
Q2 2019

Aug 14, 2019
BUY
$14.75 - $17.26 $103,073 - $120,612
6,988 Added 8.49%
89,295 $1.53 Million
Q1 2019

May 13, 2019
BUY
$13.94 - $17.58 $69,839 - $88,075
5,010 Added 6.48%
82,307 $1.33 Million
Q4 2018

Feb 14, 2019
SELL
$13.33 - $18.66 $57,385 - $80,331
-4,305 Reduced 5.28%
77,297 $1.13 Million
Q3 2018

Nov 14, 2018
SELL
$16.68 - $18.41 $11.7 Million - $12.9 Million
-703,299 Reduced 89.6%
81,602 $1.48 Million
Q2 2018

Aug 14, 2018
BUY
$16.87 - $20.3 $350,254 - $421,468
20,762 Added 2.72%
784,901 $13.2 Million
Q1 2018

May 15, 2018
BUY
$17.06 - $21.2 $813,028 - $1.01 Million
47,657 Added 6.65%
764,139 $15 Million
Q4 2017

Feb 08, 2018
SELL
$16.75 - $20.8 $2.35 Million - $2.91 Million
-140,093 Reduced 16.36%
716,482 $14.5 Million
Q3 2017

Nov 14, 2017
BUY
$11.76 - $17.4 $10.1 Million - $14.9 Million
856,575
856,575 $14.9 Million

Others Institutions Holding HALO

# of Institutions
549
Shares Held
124M
Call Options Held
668K
Put Options Held
259K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $8.89B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email